Bisogno, Iolanda
 Distribuzione geografica
Continente #
NA - Nord America 162
EU - Europa 137
AS - Asia 132
SA - Sud America 12
Totale 443
Nazione #
US - Stati Uniti d'America 160
CN - Cina 63
SG - Singapore 46
GB - Regno Unito 38
SE - Svezia 19
IE - Irlanda 16
HK - Hong Kong 15
RU - Federazione Russa 14
BR - Brasile 11
FR - Francia 11
DE - Germania 10
IT - Italia 10
AT - Austria 6
KR - Corea 5
BE - Belgio 3
FI - Finlandia 2
NL - Olanda 2
UA - Ucraina 2
AL - Albania 1
BD - Bangladesh 1
CA - Canada 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
GR - Grecia 1
IN - India 1
JO - Giordania 1
MX - Messico 1
PL - Polonia 1
Totale 443
Città #
Chandler 37
Southend 35
Dublin 16
Ashburn 15
Hong Kong 15
Singapore 15
Beijing 12
Dallas 12
Jacksonville 8
Nanjing 6
The Dalles 6
Vienna 6
Hebei 5
Lawrence 5
Princeton 5
Seoul 5
Wilmington 5
Columbus 4
Jinan 4
Munich 4
Ann Arbor 3
Brussels 3
Haikou 3
Ningbo 3
Shenyang 3
Tianjin 3
Council Bluffs 2
Dearborn 2
Falls Church 2
Guangzhou 2
Helsinki 2
Nanchang 2
New York 2
Redwood City 2
Taiyuan 2
Venezia 2
Volargne 2
Amman 1
Araruama 1
Athens 1
Boardman 1
Boston 1
Catanduva 1
Chennai 1
Concórdia 1
Cuiabá 1
Fairfield 1
Feira de Santana 1
Florianópolis 1
Guayaquil 1
Imperatriz 1
Jiaxing 1
Lanzhou 1
Lavras 1
Maceió 1
Markham 1
Mexico City 1
Newport 1
Paterson 1
Philadelphia 1
Prague 1
Santa Clara 1
Seattle 1
Sindelfingen 1
São Gabriel 1
Taboão da Serra 1
Taizhou 1
Tappahannock 1
Tirana 1
Warsaw 1
Woodbridge 1
Wuhan 1
Yuanping 1
Zhengzhou 1
Totale 297
Nome #
Immunotherapy versus standard of care in metastatic renal cell carcinoma. A systematic review and meta-analysis 108
Renal cell carcinoma in one year: Going inside the news of 2017 - A report of the main advances in RCC cancer research 97
De novo metastatic castration sensitive prostate cancer: State of art and future perspectives 97
Predictive role of changes in the tumor burden and International Metastatic Renal Cell Carcinoma Database Consortium class during active surveillance for metastatic renal cell carcinoma 83
Second-line therapy for metastatic urothelial carcinoma: Defining the best treatment option among immunotherapy, chemotherapy, and antiangiogenic targeted therapies. A systematic review and meta-analysis 69
Totale 454
Categoria #
all - tutte 2.088
article - articoli 2.088
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.176


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202124 0 0 2 9 5 4 0 0 0 0 4 0
2021/202232 0 7 1 0 4 4 0 1 1 1 1 12
2022/2023100 5 11 11 14 8 29 0 7 12 1 1 1
2023/202442 0 5 2 4 13 2 0 5 0 5 6 0
2024/2025108 1 8 4 25 1 7 1 2 24 4 12 19
2025/202650 30 20 0 0 0 0 0 0 0 0 0 0
Totale 454